Copper Peptide Complex — Tripeptide
GHK-Cu (Glycyl-L-Histidyl-L-Lysine:Copper(II)) is a naturally occurring tripeptide-copper complex first identified in human plasma by Loren Pickart in 1973. Pickart observed that liver tissue from young donors (aged 20–25) produced a factor that caused old liver tissue to synthesize proteins characteristic of youth — this factor was subsequently identified as the GHK-Cu complex. The peptide is found in plasma, saliva, and urine at measurable concentrations that decline significantly with age: from approximately 200 ng/mL in plasma at age 20 to roughly 80 ng/mL by age 60. The copper(II) ion is essential for GHK-Cu's biological activity. The tripeptide alone (GHK without copper) has minimal biological effect. The 1:1 GHK:Cu²⁺ complex forms a stable structure where the copper ion is coordinated by the glycine amine nitrogen, two amide nitrogens from the peptide backbone, and the imidazole nitrogen of histidine. This coordination geometry creates a biologically active molecule capable of modulating gene expression in over 4,000 human genes — roughly 6% of the human genome. GHK-Cu is unique among research peptides in that it is both a naturally occurring human compound and one whose plasma levels decrease with age. This biological context — a compound present in youth that declines with aging — has driven extensive research into its role in tissue remodeling, wound healing, skin biology, and the molecular mechanisms of aging.
Stimulates type I and III collagen production, elastin synthesis, and glycosaminoglycan expression in fibroblasts.
Regulates matrix metalloproteinase (MMP) activity, promoting organized tissue remodeling rather than scar formation.
Upregulates superoxide dismutase (SOD), glutathione peroxidase, and other antioxidant enzymes at the transcriptional level.
Enhances dermal wound closure through fibroblast migration, angiogenesis, and organized collagen deposition.
Increases hair follicle size and growth cycle duration in preclinical models, with evidence of follicle stem cell activation.
Reduces pro-inflammatory cytokines (IL-6, TNF-α) and TGF-β signaling, shifting tissue repair from fibrotic to regenerative.
Influences expression of over 4,000 genes — one of the broadest transcriptomic effects of any peptide studied.
Endogenously present in human plasma, providing a biological precedent for safety that synthetic peptides lack.
GHK-Cu exerts its effects through broad-spectrum gene expression modulation rather than a single receptor pathway. The copper-peptide complex enters cells and influences transcription of over 4,000 genes, with major effects on pathways controlling tissue remodeling, antioxidant defense, and inflammation. The copper ion serves as the catalytic center for many of these interactions, particularly those involving metalloprotein regulation. Collagen synthesis is stimulated through upregulation of type I and type III procollagen gene expression in fibroblasts, while simultaneously modulating matrix metalloproteinases (MMP-1, MMP-2, MMP-9) and their tissue inhibitors (TIMPs). This balanced regulation of matrix degradation and synthesis promotes organized tissue remodeling — collagen fibers align along tension lines rather than forming disorganized scar tissue. GHK-Cu also stimulates angiogenesis through VEGF and FGF-2 upregulation, providing new blood supply to healing tissues. The antioxidant effects occur at the transcriptional level: GHK-Cu upregulates superoxide dismutase (SOD1, SOD3), glutathione S-transferase, and thioredoxin expression, while simultaneously suppressing pro-oxidant genes. Additionally, GHK-Cu modulates the Wnt signaling pathway and activates the ubiquitin-proteasome system for removal of damaged proteins. The anti-inflammatory mechanism involves suppression of NF-κB-dependent cytokine production and reduction of TGF-β1 signaling that drives fibrosis — collectively shifting the tissue repair phenotype from scarring toward regeneration.
Collagen/elastin stimulation, wrinkle depth reduction, and skin thickness improvement in topical and injectable studies.
Preclinical/CosmeticAccelerated dermal wound closure with improved collagen organization and reduced scar formation in animal models.
PreclinicalHair follicle enlargement, growth cycle extension, and follicular stem cell activation research.
PreclinicalTGF-β1 suppression and MMP regulation to reduce fibrotic tissue formation — studied in lung, liver, and kidney fibrosis models.
PreclinicalGenomic studies on how GHK-Cu reverses age-related gene expression patterns toward younger profiles.
ActiveCopper-dependent stimulation of osteoblast differentiation and bone morphogenetic protein expression.
Preclinical| Period | Dose | Frequency | Notes |
|---|---|---|---|
| 1–4 | 200 mcg | Daily (SC or topical) | Standard research dose — topical at 0.01–0.1% concentration |
| 5–8 | 200 mcg | Daily (SC or topical) | Continue at maintenance dose — assess tissue response |
| 9–12 | 200 mcg | Daily or 5×/week | Extended protocols — skin biology studies often run 12+ weeks |
Bacteriostatic water contains 0.9% benzyl alcohol as a preservative. Benzyl alcohol is a metal chelator that strips the copper ion from the GHK peptide, rendering the complex biologically inactive. Always use sterile water (water for injection) without preservatives when reconstituting GHK-Cu. This is the single most important handling instruction for this peptide.
GHK-Cu is the most extensively studied copper peptide with the broadest evidence base. Other copper peptides (AHK-Cu, GHK derivatives) exist but have far less published research. GHK-Cu is unique in being a naturally occurring human peptide whose plasma levels decline with age, providing a biological rationale for supplementation research that synthetic copper peptides lack.
Yes. For skin biology research, topical application at 0.01–0.1% concentration is effective and widely used in cosmetic formulations. For systemic effects (connective tissue, bone, hair follicle research), subcutaneous injection of ~200 mcg daily is the standard research protocol. The route depends on the target tissue and research objective.
Reconstituted GHK-Cu (in sterile water) should be stored at 2–8°C and used within 14 days. The shorter shelf life compared to many other peptides reflects the absence of bacteriostatic preservative — sterile water provides no antimicrobial protection. Avoid freeze-thaw cycles. Prepare only the volume needed for 14 days.
At the standard 200 mcg dose, GHK-Cu delivers approximately 13 mcg of elemental copper — negligible compared to dietary copper intake (900 mcg RDA). The copper is chelated within the peptide complex and released in a controlled manner at the tissue level. Copper toxicity concerns would only arise at doses orders of magnitude higher than standard research protocols.
Need help choosing a peptide?
Try the AI Coach →